Jonathan Tward, MD
Radiation Oncology · Salt Lake City, UTNPI 1144415969
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $81,991 of the $113,859 with a category attached, or 72.0%. 13 manufacturers reported payments, led by Myriad Genetic Laboratories, Inc. at 24.6% of the total. Among radiation oncology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $749.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$28K
- Bayer$27K
- Bioprotect Medical, Inc.$20K
- Boston Scientific$9K
- Progenics Pharmaceuticals, Inc.$7K
- Merck$7K
- plus $16K from 7 others
Across 18 payments — averaging $12,013 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$146K
- Blue Earth Diagnostics$71K
What the payments were for
- Consulting fees$81,99172%
- Speaking & faculty fees$10,2719%
- Travel & lodging$16,15114%
- Food & beverage$5,4475%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 31 | $28,007 |
| Bayer | 39 | $27,179 |
| Bioprotect Medical, Inc. | 30 | $20,326 |
| Boston Scientific | 19 | $8,530 |
| Progenics Pharmaceuticals, Inc. | 5 | $6,754 |
| Merck | 9 | $6,599 |
| Pfizer | 6 | $6,018 |
| Blue Earth Diagnostics | 5 | $5,056 |
| Myovant Sciences Inc. | 1 | $4,850 |
| Theragenics Corporation | 2 | $227 |
| Elekta, Inc. | 1 | $134 |
| Novartis | 1 | $91 |
| Siemens Medical Solutions USA, Inc. | 3 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolaris$27,698
- BIOPROTECT BALLOON IMPLANT SYSTEM$19,847
- Xofigo$17,751
- Nubeqa$8,610
- SPACEOAR VUE$7,795
- PYLARIFY$6,754
- XTANDI$5,400
- Axumin$5,000
- ORGOVYX$4,850
How this compares
$113,859 in reported general payments places this provider in the 95th percentile of 49 radiation oncology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 109 | $2,047 |
| Bicalutamide | 13 | $210 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $109 |
| Ciprofloxacin Hcl | 16 | $53 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Salt Lake City
- David GaffneySalt Lake City$22K
- Douglas HoltSalt Lake City$3K
- Kristine KokenySalt Lake City$3K
- Matthew PoppeSalt Lake City$2K
- John HayesSalt Lake City$1K
- Shane LloydSalt Lake City$1K
- Ying HitchcockSalt Lake City$1K
- Thomas SkidmoreSalt Lake City$831
- Robert LeeSalt Lake City$752
- Amy StrowbridgeSalt Lake City$741
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.